Assessing the Role of Antioxidants in Migraine Patients in Erbil City
DOI:
https://doi.org/10.31351/vol33iss3pp47-55Keywords:
Migraine, Antioxidants, CAT, SOD, GPX1, TRX.Abstract
Migraine is a prevalent chronic condition that is often characterized by recurrent incapacitating headache attacks and related symptoms. The purpose of this investigation was to assess the potential effects of antioxidants on migraine disease. The main goal of the study was to measure the concentrations of many important antioxidants, such as catalase (CAT), superoxide dismutase (SOD), thioredoxin (TRX), and glutathione peroxidase 1 (GPX1). Ninety participants were recruited from the outpatient headache clinic of the neurology department at Al Jumhury Teaching Hospital in Erbil City for this study. In this study, there were 60 patients with migraine and 30 controls. Among the migraine group, there were 45 female and 15 male participants, while the control group consisted of 20 female and 10 male participants, with matching in terms of age and sex. According to study results, both male and female migraine patients had significantly lower levels of enzymes SOD and GPX1 compared to the control group. Additionally, female migraine patients had lower levels of CAT significantly compared to the control group. In male migraine patients, CAT also showed lower levels, but the difference was not statistically significant. On the other hand, TRX showed lower levels in both female and male migraine patients, but the difference was not statistically significant compared to the control group. There was a negative correlation observed between the frequency of headache-related days per month and the serum concentrations of SOD. This implies that as the levels of SOD in the serum decrease, the number of headache-related days per month tends to increase.
Received 29/5/2023
Accepted 21/8/2023
Published 15/9/2024
How to Cite
Publication Dates
References
Shojaei M, Sahebkar A, Khorvash F, Fallahpour S, Askari G, Bagherniya M. The effects of phytosomal curcumin supplementation on clinical symptoms, and inflammatory and oxidative stress biomarkers in patients with migraine: A protocol for a randomized double-blind placebo-controlled trial. Avicenna J Phytomed. 2023;13(1):45-57.
Altunkaynak Y, Keskek A, Donmezler S, Olgun H, Delen F, Kurt Sabitay I, et al. A study of the relationship between serum uric acid levels and pain in patients with migraine. Medicine. 2023;102(5):e32810-e.
Xu, R., Xiong, Y., Wei, X., Huang, X., Chen, Y., & Han, J. (2020). Association between psoriasis and migraine: what should we expect from a meta-analysis?.
Capi M, Lionetto L, De Angelis V, Martelletti P. Migraine Versus Cluster Headache and Potential Other Indications. Monoclonal Antibodies in Headache: From Bench to Patient: Springer; 2021. p. 167-72.
Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache: J Headache Pain. 2019;59(3):306-38.
Al-Fayyadh MS, Wadood SA. Effects of Red Cabbage and Garlic Extracts on Oxidative Stress Induced by Fumonisin B1. Iraqi J. Sci. 2021:1850-61.
Nwachukwu ID, Sarteshnizi RA, Udenigwe CC, Aluko RE. A concise review of current in vitro chemical and cell-based antioxidant assay methods. Molecules. 2021;26(16):4865.
Gusti AM, Qusti SY, Alshammari EM, Toraih EA, Fawzy MS. Antioxidants-related superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione-S-transferase (GST), and nitric oxide synthase (NOS) gene variants analysis in an obese population: A preliminary case-control study. Antioxidants. 2021;10(4):595.
Ron-Doitch S, Kohen R. The cutaneous physiological redox: Essential to maintain but difficult to define. Antioxidants. 2020;9(10):942.
Mohammadi F, Soltani A, Ghahremanloo A, Javid H, Hashemy SI. The thioredoxin system and cancer therapy: a review. Cancer Chemother Pharmacol. 2019;84:925-35.
Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J. International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: Demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016;36(3):240-8.
Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017.
Margis R, Dunand C, Teixeira FK, Margis‐Pinheiro M. Glutathione peroxidase family–an evolutionary overview. The FEBS journal. 2008;275(15):3959-70.
Power JH, Blumbergs PC. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117:63-73.
Gharib E, Gardaneh M, Shojaei S. Upregulation of Glutathione Peroxidase-1 Expression and Activity by Glial Cell Line–Derived Neurotrophic Factor Promotes High-Level Protection of PC12 Cells Against 6-Hydroxydopamine and Hydrogen Peroxide Toxicities. Rejuvenation Res. 2013;16(3):185-99.
Ferroni P, Barbanti P, Della-Morte D, Palmirotta R, Jirillo E, Guadagni F. Redox mechanisms in migraine: novel therapeutics and dietary interventions. Antioxidants & redox signaling. 2018;28(12):1144-83.
Ciancarelli I, Morone G, Tozzi Ciancarelli MG, Paolucci S, Tonin P, Cerasa A, et al., editors. Identification of Determinants of Biofeedback Treatment’s Efficacy in Treating Migraine and Oxidative Stress by ARIANNA (ARtificial Intelligent Assistant for Neural Network Analysis). Healthcare; 2022: MDPI.
Contreras-Zentella ML, Villalobos-García D, Hernández-Muñoz R. Ethanol metabolism in the liver, the induction of oxidant stress, and the antioxidant defense system. Antioxidants. 2022;11(7):1258.
Bolayir E, Celik K, Kugu N, Yilmaz A, Topaktas S, Bakir S. Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc. 2004;67(6):263-7.
Bockowski L, Sobaniec W, Kulak W, Smigielska-Kuzia J, Bockowski L, Sobaniec W, et al. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep. 2008;60(4):542.
Aytaç B, Coşkun Ö, Alioğlu B, Durak ZE, Büber S, Tapçi E, et al. Decreased antioxidant status in migraine patients with brain white matter hyperintensities. Neurol Sci. 2014;35:1925-9.
Togha M, Razeghi Jahromi S, Ghorbani Z, Ghaemi A, Rafiee P. An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study. BMC Neurol. 2019;19(1):1-10.
Neri M, Frustaci A, Milic M, Valdiglesias V, Fini M, Bonassi S, et al. A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine. Cephalalgia. 2015;35(10):931-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
